Publications by authors named "Roxana Drake"

Claim this Profile
E
Ensovibep, a SARS-CoV-2 antiviral designed ankyrin repeat protein, is safe and well tolerated in healthy volunteers: Results of a first-in-human, ascending single-dose Phase 1 study.
Nina Stojcheva, Stacy Gladman, Marianne Soergel, Christof Zitt, Roxana Drake

Br J Clin Pharmacol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID-19: A phase 2a, open-label, single-dose escalation study.
Manon L M Prins, Johan L van der Plas, Maurits F J M Vissers, Cécile L Berends, Gaby Tresch, Roxana F Drake

Br J Clin Pharmacol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis